<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39403283</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>U-Net-based computed tomography quantification of viral pneumonia can predict fibrotic interstitial lung abnormalities at 3-month follow-up.</ArticleTitle><Pagination><StartPage>1435337</StartPage><MedlinePgn>1435337</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1435337</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1435337</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Given the high prevalence of fibrotic interstitial lung abnormalities (ILAs) post-COVID-19, this study aims to evaluate the effectiveness of quantitative CT features in predicting fibrotic ILAs at 3-month follow-up.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This retrospective study utilized cohorts from distinct clinical settings: the training dataset comprised individuals presenting at the fever clinic and emergency department, while the validation dataset included patients hospitalized with COVID-19 pneumonia. They were classified into fibrotic group and nonfibrotic group based on whether the fibrotic ILAs were present at follow-up. A U-Net-based AI tool was used for quantification of both pneumonia lesions and pulmonary blood volumes. Receiver operating characteristic (ROC) curve analysis and multivariate analysis were used to assess their predictive abilities for fibrotic ILAs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among the training dataset, 122 patients (mean age of 68 years ±16 [standard deviation], 73 men), 55.74% showed fibrotic ILAs at 3-month follow-up. The multivariate analysis identified the pneumonia volume [PV, odd ratio (OR) 3.28, 95% confidence interval (CI): 1.20-9.31, <i>p</i> = 0.02], consolidation volume (CV, OR 3.77, 95% CI: 1.37-10.75, <i>p</i> = 0.01), ground-glass opacity volume (GV, OR 3.38, 95% CI: 1.26-9.38, <i>p</i> = 0.02), pneumonia mass (PM, OR 3.58, 95% CI: 1.28-10.46, <i>p</i> = 0.02), and the CT score (OR 12.06, 95% CI: 3.15-58.89, <i>p</i> &lt; 0.001) as independent predictors of fibrotic ILAs, and all quantitative parameters were as effective as CT score (all <i>p</i> &gt; 0.05). And the area under the curve (AUC) values were PV (0.79), GV (0.78), PM (0.79), CV (0.80), and the CT score (0.77). The validation dataset, comprising 45 patients (mean age 67.29 ± 14.29 years, 25 males) with 57.78% showing fibrotic ILAs at follow-up, confirmed the predictive validity of these parameters with AUC values for PV (0.86), CV (0.90), GV (0.83), PM (0.88), and the CT score (0.85). Additionally, the percentage of blood volume in vessels &lt;5mm<sup>2</sup> relative to the total pulmonary blood volume (BV5%) was significantly lower in patients with fibrotic ILAs (<i>p</i> = 0.048) compared to those without.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">U-Net based quantification of pneumonia lesion and BV5% on baseline CT scan has the potential to predict fibrotic ILAs at follow-up in COVID-19 patients.</AbstractText><CopyrightInformation>Copyright © 2024 Ying, Zhu, Hu, Pan, Tan, Han, Wu, Zhou, Wang, Song, Song and Jin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ying</LastName><ForeName>Zhoumeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>4+4 Medical Doctor Program, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhu</LastName><ForeName>Zhenchen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Ge</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Theranostics and Translational Research Center, National Infrastructures for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Zhengsong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>4+4 Medical Doctor Program, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Weixiong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Deepwise AI Lab, Beijing Deepwise and League of PhD Technology Co. Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Statistics, Institute of Basic Medicine Sciences, School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Zifeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Deepwise AI Lab, Beijing Deepwise and League of PhD Technology Co. Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Deepwise AI Lab, Beijing Deepwise and League of PhD Technology Co. Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Lan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Zhengyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">interstitial</Keyword><Keyword MajorTopicYN="N">lung diseases</Keyword><Keyword MajorTopicYN="N">multidetector computed tomography</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">pulmonary fibrosis</Keyword></KeywordList><CoiStatement>WT, ZW, and ZZhou were employed by Beijing Deepwise and League of PhD Technology Co. Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39403283</ArticleId><ArticleId IdType="pmc">PMC11471527</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1435337</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Atabati E, Dehghani-Samani A, Mortazavimoghaddam SG. Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: a narrative review. Can J Respir Ther. (2020) 56:70–8. doi: 10.29390/cjrt-2020-021</Citation><ArticleIdList><ArticleId IdType="doi">10.29390/cjrt-2020-021</ArticleId><ArticleId IdType="pmc">PMC7690312</ArticleId><ArticleId IdType="pubmed">33274259</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WJ, Tang XX. Virus infection induced pulmonary fibrosis. J Transl Med. (2021) 19:496. doi: 10.1186/s12967-021-03159-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03159-9</ArticleId><ArticleId IdType="pmc">PMC8649310</ArticleId><ArticleId IdType="pubmed">34876129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng G, Chen P, Wei Y, Yue H, Chu J, Zhao J, et al. . Viral infection increases the risk of idiopathic pulmonary fibrosis: a Meta-analysis. Chest. (2020) 157:1175–87. doi: 10.1016/j.chest.2019.10.032, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.10.032</ArticleId><ArticleId IdType="pmc">PMC7214095</ArticleId><ArticleId IdType="pubmed">31730835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hata A, Schiebler ML, Lynch DA, Hatabu H. Interstitial lung abnormalities: state of the art. Radiology. (2021) 301:19–34. doi: 10.1148/radiol.2021204367, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021204367</ArticleId><ArticleId IdType="pmc">PMC8487219</ArticleId><ArticleId IdType="pubmed">34374589</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatabu H, Hunninghake GM, Richeldi L, Brown KK, Wells AU, Remy-Jardin M, et al. . Interstitial lung abnormalities detected incidentally on CT: a position paper from the Fleischner society. Lancet Respir Med. (2020) 8:726–37. doi: 10.1016/S2213-2600(20)30168-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30168-5</ArticleId><ArticleId IdType="pmc">PMC7970441</ArticleId><ArticleId IdType="pubmed">32649920</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Chen L, Fan Y, Alwalid O, Jia X, Zheng Y, et al. . Longitudinal assessment of chest CT findings and pulmonary function after COVID-19 infection. Radiology. (2023) 307:e222888. doi: 10.1148/radiol.222888, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.222888</ArticleId><ArticleId IdType="pmc">PMC9969419</ArticleId><ArticleId IdType="pubmed">36786698</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. (2020) 20:533–4. doi: 10.1016/S1473-3099(20)30120-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy HM, Batiha GES, Faidah H, Al-Gareeb AI, Saad HM, Simal-Gandara J. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals. Inflammopharmacology. (2022) 30:2017–26. doi: 10.1007/s10787-022-01027-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-022-01027-6</ArticleId><ArticleId IdType="pmc">PMC9430017</ArticleId><ArticleId IdType="pubmed">36044102</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizera J, Genzor S, Sova M, Stanke L, Burget R, Jakubec P, et al. . The effectiveness of glucocorticoid treatment in post-COVID-19 pulmonary involvement. Pneumonia (Nathan). (2024) 16:2. doi: 10.1186/s41479-023-00123-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41479-023-00123-7</ArticleId><ArticleId IdType="pmc">PMC10840187</ArticleId><ArticleId IdType="pubmed">38311783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassan S, Tesar T, Tisonova J, Lassanova M. Pharmacological approaches to pulmonary fibrosis following COVID-19. Front Pharmacol. (2023) 14:1143158. doi: 10.3389/fphar.2023.1143158, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1143158</ArticleId><ArticleId IdType="pmc">PMC10308083</ArticleId><ArticleId IdType="pubmed">37397477</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong-Quy S, Vo-Pham-Minh T, Tran-Xuan Q, Huynh-Anh T, Vo-Van T, Vu-Tran-Thien Q, et al. . Post-COVID-19 pulmonary fibrosis: facts—challenges and futures: a narrative review. Pulm Ther. (2023) 9:295–307. doi: 10.1007/s41030-023-00226-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41030-023-00226-y</ArticleId><ArticleId IdType="pmc">PMC10199290</ArticleId><ArticleId IdType="pubmed">37209374</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasin R, Gomaa AAK, Ghazy T, Hassanein SA, Ibrahem RA, Khalifa MH. Predicting lung fibrosis in post-COVID-19 patients after discharge with follow-up chest CT findings. Egypt J Radiol Nucl Med. (2021) 52:495. doi: 10.1186/s43055-021-00495-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-021-00495-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Alilou S, Zangiabadian M, Pouramini A, Jaberinezhad M, Shobeiri P, Ghozy S, et al. . Radiological findings as predictors of COVID-19 lung sequelae: a systematic review and Meta-analysis. Acad Radiol. (2023) 30:3076–85. doi: 10.1016/j.acra.2023.06.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2023.06.002</ArticleId><ArticleId IdType="pmc">PMC10242153</ArticleId><ArticleId IdType="pubmed">37491177</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Liu Y, Xu D, Zhang R, Lan L, Xu H. Prediction of the development of pulmonary fibrosis using serial thin-section CT and clinical features in patients discharged after treatment for COVID-19 pneumonia. Korean J Radiol. (2020) 21:746–55. doi: 10.3348/kjr.2020.0215, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3348/kjr.2020.0215</ArticleId><ArticleId IdType="pmc">PMC7231610</ArticleId><ArticleId IdType="pubmed">32410413</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao G, Feng Q, Chen C, Zhou Z, Yu Y. Diagnose like a radiologist: hybrid neuro-probabilistic reasoning for attribute-based medical image diagnosis. IEEE Trans Pattern Anal Mach Intell. (2022) 44:7400–16. doi: 10.1109/TPAMI.2021.3130759</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TPAMI.2021.3130759</ArticleId><ArticleId IdType="pubmed">34822325</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Liu X, Shen J, Li Z, Sang Y, Wu X, et al. . Clinically applicable AI system for accurate diagnosis, quantitative measurements, and prognosis of COVID-19 pneumonia using computed tomography. Cell. (2020) 181:1423–1433.e11. doi: 10.1016/j.cell.2020.04.045, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.045</ArticleId><ArticleId IdType="pmc">PMC7196900</ArticleId><ArticleId IdType="pubmed">32416069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou HY, Yu Y, Wang C, Zhang S, Gao Y, Pan J, et al. . A transformer-based representation-learning model with unified processing of multimodal input for clinical diagnostics. Nat Biomed Eng. (2023) 7:743–55. doi: 10.1038/s41551-023-01045-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-023-01045-x</ArticleId><ArticleId IdType="pubmed">37308585</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso D, Guido G, Zerunian M, Polidori T, Lucertini E, Pucciarelli F, et al. . Postacute sequelae of COVID-19 pneumonia: 6-month chest CT follow-up. Radiology. (2021) 301:E396–405. doi: 10.1148/radiol.2021210834</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210834</ArticleId><ArticleId IdType="pmc">PMC8335814</ArticleId><ArticleId IdType="pubmed">34313468</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Zhang Q, Huang C, Shi C, Wang L, Shi N, et al. . CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics. (2020) 10:5613–22. doi: 10.7150/thno.45985, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.45985</ArticleId><ArticleId IdType="pmc">PMC7196293</ArticleId><ArticleId IdType="pubmed">32373235</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris MF, Pershad Y, Kang P, Ridenour L, Lavon B, Lanclus M, et al. . Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease. Eur Respir J. (2021) 58:2004133. doi: 10.1183/13993003.04133-2020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04133-2020</ArticleId><ArticleId IdType="pmc">PMC7908189</ArticleId><ArticleId IdType="pubmed">33632795</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansell DM, Bankier AA, Mac Mahon H, McLoud TC, Müller NL, Remy J. Fleischner society: glossary of terms for thoracic imaging. Radiology. (2008) 246:697–722. doi: 10.1148/radiol.2462070712</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2462070712</ArticleId><ArticleId IdType="pubmed">18195376</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, So M, Iwagami M, Fukunaga K, Takagi H, Kabata H, et al. . One-year follow-up CT findings in COVID-19 patients: a systematic review and meta-analysis. Respirology. (2022) 27:605–16. doi: 10.1111/resp.14311, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14311</ArticleId><ArticleId IdType="pmc">PMC9350074</ArticleId><ArticleId IdType="pubmed">35694728</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchino M, Lieto R, Romano F, Sica G, Bocchini G, Muto E, et al. . Chest CT-based assessment of 1-year outcomes after moderate COVID-19 pneumonia. Radiology. (2022) 305:479–85. doi: 10.1148/radiol.220019</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220019</ArticleId><ArticleId IdType="pmc">PMC9619196</ArticleId><ArticleId IdType="pubmed">35536134</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. . Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. (2020) 295:715–21. doi: 10.1148/radiol.2020200370, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200370</ArticleId><ArticleId IdType="pmc">PMC7233367</ArticleId><ArticleId IdType="pubmed">32053470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Wang X, Zhou Z, Wu Z, Feng Q, Qi J. Pulmonary segments segmentation with hierarchical weak labels. IEEE 20th International Symposium on Biomedical Imaging (ISBI), pp. 1–5. (2023).</Citation></Reference><Reference><Citation>Luger AK, Sonnweber T, Gruber L, Schwabl C, Cima K, Tymoszuk P, et al. . Chest CT of lung injury 1 year after COVID-19 pneumonia: the Cov ILD study. Radiology. (2022) 304:462–70. doi: 10.1148/radiol.211670, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.211670</ArticleId><ArticleId IdType="pmc">PMC8988857</ArticleId><ArticleId IdType="pubmed">35348379</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Tonkin J, Devaraj A, Philip KEJ, Orton CM, Desai SR, et al. . CT lung abnormalities after COVID-19 at 3 months and 1 year after hospital discharge. Radiology. (2022) 303:444–54. doi: 10.1148/radiol.2021211746, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211746</ArticleId><ArticleId IdType="pmc">PMC8515207</ArticleId><ArticleId IdType="pubmed">34609195</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchino M, Rea G, Capitelli L, Lieto R, Bruzzese D. Chest CT lung abnormalities 1 year after COVID-19: a systematic review and Meta-analysis. Radiology. (2023) 308:e230535. doi: 10.1148/radiol.230535, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.230535</ArticleId><ArticleId IdType="pubmed">37404150</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd El Megid AGI, El Shabrawy M, Abdalla AAEHM. Correlation between chest CT severity scoring system with oxygen saturation and laboratory inflammatory markers in adult patients with COVID-19 infection. Egypt J Radiol Nucl Med. (2022) 53:747. doi: 10.1186/s43055-022-00747-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-022-00747-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli C, Piccarducci R, Marchetti L, Romei C, Martini C. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients. Biochem Pharmacol. (2021) 193:114812. doi: 10.1016/j.bcp.2021.114812, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2021.114812</ArticleId><ArticleId IdType="pmc">PMC8546906</ArticleId><ArticleId IdType="pubmed">34687672</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu P, Liu X, Zhang R, Shi L, Gao J. The performance of chest CT in evaluating the clinical severity of COVID-19 pneumonia: identifying critical cases based on CT characteristics. Investig Radiol. (2020) 55:412–21. doi: 10.1097/RLI.0000000000000689</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLI.0000000000000689</ArticleId><ArticleId IdType="pmc">PMC7173027</ArticleId><ArticleId IdType="pubmed">32304402</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed I, de Broucker V, Duhamel A, Giordano J, Ego A, Fonne N, et al. . Pulmonary circulation abnormalities in post-acute COVID-19 syndrome: dual-energy CT angiographic findings in 79 patients. Eur Radiol. (2023) 33:4700–12. doi: 10.1007/s00330-023-09618-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-023-09618-9</ArticleId><ArticleId IdType="pmc">PMC10129318</ArticleId><ArticleId IdType="pubmed">37145145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchler T, Günthner R, Ribeiro A, Hausinger R, Streese L, Wöhnl A, et al. . Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation. Angiogenesis. (2023) 26:547–63. doi: 10.1007/s10456-023-09885-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-023-09885-6</ArticleId><ArticleId IdType="pmc">PMC10542303</ArticleId><ArticleId IdType="pubmed">37507580</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>